MELBOURNE, AUSTRALIA, Jul. 7 (Korea Bizwire) – New Automatic Brain Metastases Planning software has been used for the first time in Australia at Epworth HealthCare in Richmond to deliver a tailored radiosurgery treatment to a patient with metastatic brain cancer. The patient, a 48-year-old woman with metastatic brain tumors from a primary melanoma, had dose delivered to ten metastases during her 25 minute treatment.
The current standard treatment of multiple metastases, known as Whole Brain Radiation Therapy (WBRT), involves applying radiation to the entire brain which can lead to cognitive deficits. Automatic Brain Metastases Planning uses a patented algorithm to deliver highly conformal treatments while minimizing dose spread to surrounding normal tissue.
“Automatic Brain Metastases Planning offers the opportunity to not only efficiently and effectively treat brain metastases, but also help us to prevent unnecessary loss of brain function that can occur with whole brain radiation therapy, such as memory loss or other cognitive deficits,” commented Michael Dally, radiation oncologist at Epworth.
When targeted with stereotactic radiosurgery individually, total treatment time increases for each metastasis at the same rate as the number of targets. Automatic Brain Metastases Planning, however, allows for time-efficient precision targeting of several metastases in a single session, taking advantage of the rotation of the machine to deliver a conformity plan.
“As the first hospital in Asia Pacific to offer Automatic Brain Metastases Planning treatments, Epworth is poised to become a leading facility in the region for the treatment of multiple brain metastases as well as contributing to the overall advancements of stereotactic radiosurgery developments,” said Phil Cardamone, President Asia/Pacific at Brainlab.
To learn more about Automatic Brain Metastases Planning, visit brainlab.com/brainmets.
Epworth HealthCare is Victoria’s largest not for profit private health care group, renowned for excellence in diagnosis, treatment, care and rehabilitation. Epworth is located across the Melbourne metropolitan area, with seven hospital sites and three specialist centres.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to and consistency of advanced, less invasive patient treatment.
Core products revolve around information-guided surgery, precision radiation therapy, and information and knowledge sharing that fosters interdisciplinary collaboration. Brainlab technology currently powers treatments in the fields of neurosurgery, radiosurgery/radiotherapy, orthopedics, ENT, CMF, spine, and trauma.
Privately held since its formation in 1989, Brainlab has more than 9,000 systems installed in about 100 countries. Brainlab employs 1,200 people in 18 offices worldwide, including 300 research & development engineers, who form a crucial part of the product development team.
To learn more, visit www.brainlab.com.
Marketing Communications Manager
P: +49 89 99 15 68
Source: Brainlab via Marketwired